503 related articles for article (PubMed ID: 9316393)
1. Peptide binding by class I and class II MHC molecules.
Batalia MA; Collins EJ
Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
[TBL] [Abstract][Full Text] [Related]
2. Peptide binding to MHC class I and II proteins: new avenues from new methods.
Yaneva R; Schneeweiss C; Zacharias M; Springer S
Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
4. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
5. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
6. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and evaluation of MHC class II binding peptides.
de Haan EC; Wauben MH; Grosfeld-Stulemeyer MC; Moret EE
Biologicals; 2001; 29(3-4):289-92. PubMed ID: 11851330
[TBL] [Abstract][Full Text] [Related]
8. MHC class I/peptide interactions: binding specificity and kinetics.
Margulies DH; Corr M; Boyd LF; Khilko SN
J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
Persson K; Schneider G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
[TBL] [Abstract][Full Text] [Related]
10. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
[TBL] [Abstract][Full Text] [Related]
11. Physical association between MHC class I molecules and immunogenic peptides.
Bouillot M; Choppin J; Cornille F; Martinon F; Papo T; Gomard E; Fournie-Zaluski MC; Levy JP
Nature; 1989 Jun; 339(6224):473-5. PubMed ID: 2786149
[TBL] [Abstract][Full Text] [Related]
12. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.
Ishioka GY; Adorini L; Guery JC; Gaeta FC; LaFond R; Alexander J; Powell MF; Sette A; Grey HM
J Immunol; 1994 May; 152(9):4310-9. PubMed ID: 8157954
[TBL] [Abstract][Full Text] [Related]
13. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
14. Cell surface expression of class II MHC proteins bound by a single peptide.
Ignatowicz L; Winslow G; Bill J; Kappler J; Marrack P
J Immunol; 1995 Apr; 154(8):3852-62. PubMed ID: 7706725
[TBL] [Abstract][Full Text] [Related]
15. MHC class I-peptide interactions and TCR recognition.
Young AC; Zhang W; Sacchettini JC; Nathenson SG
Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
[TBL] [Abstract][Full Text] [Related]
16. Enhancing cytotoxic T cell responses with altered-peptide ligands.
Zhao R; Collins EJ
Arch Immunol Ther Exp (Warsz); 2001; 49(4):271-7. PubMed ID: 11726029
[TBL] [Abstract][Full Text] [Related]
17. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of MHC class I molecules with bound peptide antigens.
Wilson IA; Fremont DH
Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
[TBL] [Abstract][Full Text] [Related]
19. Kinetic isomers of a class II MHC-peptide complex.
Schmitt L; Boniface JJ; Davis MM; McConnell HM
Biochemistry; 1998 Dec; 37(50):17371-80. PubMed ID: 9860852
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
